Cargando…
Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
BACKGROUND: Extensively drug-resistant Gram-negative bacterial (XDR-GNB) bloodstream infection (BSI) is difficult to treat and is associated with a high mortality rate in patients with hematological diseases. The aim of this study is to investigate the predisposing risk factors and the efficacy of t...
Autores principales: | Zhou, Li, Feng, Shanglong, Sun, Guangyu, Tang, Baolin, Zhu, Xiaoyu, Song, Kaidi, Zhang, Xuhan, Lu, Huaiwei, Liu, Huilan, Sun, Zimin, Zheng, Changcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396657/ https://www.ncbi.nlm.nih.gov/pubmed/30881053 http://dx.doi.org/10.2147/IDR.S191462 |
Ejemplares similares
-
The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study
por: Ge, Jing, et al.
Publicado: (2018) -
Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival
por: Tong, Juan, et al.
Publicado: (2021) -
Transplants of unrelated cord blood or sibling allogeneic peripheral blood stem cells/bone marrow in adolescent and young adults with chronic myeloid leukemia: comparable outcomes but better chronic GVHD-free and relapse-free survival among survivors with cord blood
por: Zheng, Changcheng, et al.
Publicado: (2017) -
Impact Of ELN Risk Stratification, Induction Chemotherapy Regimens And Hematopoietic Stem Cell Transplantation On Outcomes In Hyperleukocytic Acute Myeloid Leukemia With Initial White Blood Cell Count More Than 100 × 10(9)/L
por: Feng, Shanglong, et al.
Publicado: (2019) -
A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients
por: Zhou, Li, et al.
Publicado: (2016)